# Non-analgesic Effects Produced by Equipotent Analgesic Doses of Sufentanil, Hydromorphone, and Oxycodone

> **NCT04396587** · PHASE4 · COMPLETED · sponsor: **Peking University People's Hospital** · enrollment: 80 (actual)

## Conditions studied

- Opioid Use

## Interventions

- **DRUG:** Sufentanil
- **DRUG:** Hydromorphone
- **DRUG:** Oxycodone
- **DRUG:** normal Saline

## Key facts

- **NCT ID:** NCT04396587
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-20
- **Primary completion:** 2023-01-01
- **Final completion:** 2023-06-01
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2024-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04396587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04396587, "Non-analgesic Effects Produced by Equipotent Analgesic Doses of Sufentanil, Hydromorphone, and Oxycodone". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04396587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*